maybe this is it - they wouldn't schedule something like this to present bad news, would they???
Amedica to Present 24-Month CASCADE Clinical Trial Results
Date : 02/18/2016 @ 9:15AM
Source : GlobeNewswire Inc.
Stock : Amedica Corp. (MM) (AMDA)
Quote : 1.82 0.0 (0.00%) @ 9:20AM
Amedica to Present 24-Month CASCADE Clinical Trial Results
Print
Alert
AMEDICA CORP (NASDAQ:AMDA)
Intraday Stock Chart
Today : Thursday 18 February 2016
Click Here for more AMEDICA CORP Charts.
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that it will host a conference call and live webcast to present the 24-month clinical results from a blinded, randomized clinical trial (CASCADE) that compared spinal fusion between its composite silicon nitride fusion devices with a central, cancellous ceramic core, to the industry standard of PEEK spacers filled with bone autograft.
Principal investigator Mark P. Arts, M.D., Ph.D., Neurosurgeon from the Medical Center Haaglanden, The Hague, Netherlands will present the data and Dr. Sonny Bal, Chairman and CEO of Amedica Corporation will discuss its impact on the business. Details related to this call are as follows:
Date: Monday March 7, 2016
Time: 2:00 p.m. Eastern Time
Conference ID: 55371714
Dial-in: Toll-free (855) 455-6055
International (484) 756-4308
Webcast: www.amedica.com
For those who are not available to listen to the live webcast, the call will be archived on the investor relations section of the Amedica website under Events & Presentations.